Tenderwize
Zurück zur Suche

Open-house rebate agreements for Nitrendipin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitrendipin, ATC C08CA08

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

52 / 100

Komplexität

58 / 100

Risikofaktoren

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive supply/rebate agreements for pharmaceutical products containing Nitrendipin (ATC C08CA08).
  • Open-house model with uniform terms for all participating pharmaceutical companies.
Vollständige Zusammenfassung anzeigen

This is an open-house pharmaceutical supply notice for non-exclusive rebate agreements on the active substance Nitrendipin (ATC C08CA08) for AOK Rheinland-Pfalz/Saarland. The model is not a standard competitive public procurement, but the notice still sets formal submission and eligibility conditions. Contracts can start from 01.06.2025 and run for up to 24 months, with monthly entry possible during the term. No contract value is stated. Procurement documents are available via a URL, but no extracted contract document text was provided, so they were not analyzed.

Risiken

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Only authorized and marketable medicines in Germany may be supplied under the contract.

Administrative

  • If the product is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided.
  • The AMIce extract must show name, MA holder or other marketing authorization basis, dosage form, active substance, and marketability.

Auftraggeber

Lose (1)

LOT-0001

Open-house rebate agreements for Nitrendipin

Single lot covering non-exclusive open-house rebate agreements for medicines containing the active substance Nitrendipin (ATC C08CA08). The scope excludes children’s medicines on the BfArM list under §35(5a) SGB V. The buyer states that terms are uniform for all participants, with no individual negotiations. Information in this lot comes from the structured data and XML notice.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
236770-2025

Dokumente (1)

Ähnliche Ausschreibungen